ViiV Healthcare's Cabenuva Shows Superiority In HIV Viral Load Suppression: Interim Trial Analysis finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
ViiV Healthcare announces promising results from LATITUDE phase III trial, showing long-acting HIV treatment Cabenuva's superiority over daily oral therapy.
Pharmaceutical corporation ViiV must make life-saving HIV prevention injection affordable and available – Doctors Without Borders iol.co.za - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iol.co.za Daily Mail and Mail on Sunday newspapers.